Cosmo Pharmaceuticals N.V.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Cosmo Pharmaceuticals N.V. - overview
Established
1997
Location
Dublin, -, Ireland
Primary Industry
Pharmaceuticals
About
Cosmo Pharmaceuticals N. V. is a pharmaceutical company focused on providing comprehensive services for the production and regulatory compliance of pharmaceutical products. Their expertise ensures quality and efficacy in drug development and market readiness.
Cosmo Pharmaceuticals N. V. operates in the pharmaceutical sector, offering specialized services related to the production of pharmaceutical products. The company was founded in 1997 and is headquartered in Dublin, Ireland.
It has engaged in a total of 5 deals, most recently securing EUR 2. 40 mn in a GROWTH funding round from Invision, marking a total capital raise of EUR 2. 40 mn. The CEO, Alessandro Della Chà, has a background in leading pharmaceutical initiatives, although no information about previous company foundations is available.
Cosmo Pharmaceuticals N. V. specializes in a range of services related to pharmaceutical product production, including the assessment of manufacturing processes, technology transfer, stability evaluations, and market testing. The firm assists pharmaceutical manufacturers and developers in ensuring compliance and efficacy, catering to clients across North America, Europe, and Asia.
In 2021, Cosmo Pharmaceuticals generated a revenue of EUR 7,260,032. 40, with an EBITDA of EUR -1,966,135. 50. The company primarily engages in B2B transactions, with contracts that define the scope of work for services like technology transfers and stability testing, thereby establishing a structured payment framework based on service complexity.
Cosmo Pharmaceuticals N. V. is currently focused on expanding its product offerings and geographic presence. The recent funding secured in a PIPE transaction from Dievini will support these initiatives, although specific upcoming product launches or new market expansions have not been detailed.
The company aims to leverage its recent capital to enhance service capabilities and explore new market opportunities.
Current Investors
Dievini
Primary Industry
Pharmaceuticals
Sub Industries
Specialty Pharmaceuticals
Website
www.cosmopharmaceuticals.com
Company Stage
Mature
Total Amount Raised
Subscriber access only
Cosmo Pharmaceuticals N.V. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Private Placement/Follow on | Completed | Cosmo Pharmaceuticals N.V. | - | ||||||||
| Private Placement/Follow on | Completed | Cosmo Pharmaceuticals N.V. | - | ||||||||
| IPO | Completed | Cosmo Pharmaceuticals N.V. | - | ||||||||
| Growth | Completed | Cosmo Pharmaceuticals N.V. | - | ||||||||
| PIPE | Completed | Cosmo Pharmaceuticals N.V. | - |
Displaying 1 - 5 of 5
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.